raloxifene hydrochloride has been researched along with Endometriosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Mourad, SM; van Hoesel, MH; Wan, Q; Zheng, A | 1 |
| Groothuis, PG; Guo, SW | 1 |
| Alvarez, P; Bogen, O; Levine, JD | 1 |
| Altintas, D; Cetinkaya, MB; Kandemir, B; Kokcu, A; Tosun, M | 1 |
| Chao, KC; Chen, YJ; Chou, TY; Huang, CH; Li, HY; Liu, YN; Twu, NF; Wang, PH; Yang, MH; Yen, MS | 1 |
| Karp, BI; Nieman, LK; Silberstein, SD; Sinaii, N; Stratton, P | 1 |
| Hsu, AL; Nieman, LK; Segars, J; Sinaii, N; Stratton, P | 1 |
| McLaren, JS; Morris, E; Rymer, J | 1 |
| Busacca, M; Chiodo, I; Infantino, M; Matrone, R; Somigliana, E; Viganò, P; Vignali, M | 1 |
| Chiodini, A; Odorizzi, MP; Pompei, F; Somigliana, E; Viganò, P | 1 |
| Leondires, M; Nieman, LK; Parker, JD; Premkumar, A; Sinaii, N; Stratton, P | 1 |
| Guo, SW; Olive, DL | 1 |
| Liu, S; Merino, M; Nieman, LK; Segars, J; Sinaii, N; Stegmann, BJ; Stratton, P | 1 |
| Koziol, D; Nieman, LK; Segars, J; Sinaii, N; Stratton, P; Wesley, R; Winkel, C; Zimmer, C | 1 |
| Butterworth, M; Greaves, P; Green, A; Parrott, E; White, IN | 1 |
| Bergqvist, A; Bruse, C; Carlberg, M; Carlström, K; Guan, YM | 1 |
6 review(s) available for raloxifene hydrochloride and Endometriosis
| Article | Year |
|---|---|
Selective oestrogen receptor modulators (SERMs) for endometriosis.
Topics: Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Pelvic Pain; Placebos; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2021 |
Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
Topics: Adenomyosis; Clinical Trials as Topic; Drug Development; Endometriosis; Female; Hormone Antagonists; Humans; Infliximab; Oxazoles; Progesterone; Raloxifene Hydrochloride; Treatment Outcome | 2018 |
Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Endometriosis; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Leiomyoma; Lipids; Menstruation Disturbances; Norpregnenes; Parathyroid Hormone; Premenstrual Syndrome; Raloxifene Hydrochloride; Uterine Diseases; Vitamin D | 2012 |
Endometriosis: novel etiopathogenetic concepts and clinical perspectives.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Endometriosis; Enzyme Inhibitors; Female; Humans; Immunity, Cellular; MEDLINE; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Postmenopause; Raloxifene Hydrochloride; Rectal Diseases; Selective Estrogen Receptor Modulators; Vaginal Diseases | 2002 |
[The therapy of endometriosis. New prospects].
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Clinical Trials as Topic; Drug Evaluation, Preclinical; Endometriosis; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Hypothalamo-Hypophyseal System; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Papio; Pregnancy; Pregnancy Rate; Raloxifene Hydrochloride; Rats; Recurrence; Selective Estrogen Receptor Modulators; Tissue Adhesions | 2003 |
Two unsuccessful clinical trials on endometriosis and a few lessons learned.
Topics: Adult; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Middle Aged; Needs Assessment; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Severity of Illness Index; Species Specificity; Treatment Failure | 2007 |
4 trial(s) available for raloxifene hydrochloride and Endometriosis
| Article | Year |
|---|---|
Migraine in women with chronic pelvic pain with and without endometriosis.
Topics: Adolescent; Adult; Chronic Disease; Combined Modality Therapy; Endometriosis; Estrogen Antagonists; Female; Humans; Laparoscopy; Middle Aged; Migraine Disorders; Pelvic Pain; Placebos; Prevalence; Prospective Studies; Quality of Life; Raloxifene Hydrochloride; Young Adult | 2011 |
Relating pelvic pain location to surgical findings of endometriosis.
Topics: Adolescent; Adult; Biopsy; Bone Density Conservation Agents; Chronic Disease; Endometriosis; Female; Humans; Laparoscopy; Middle Aged; Pelvic Pain; Raloxifene Hydrochloride; Young Adult | 2011 |
Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Laparoscopy; Pelvic Pain; Raloxifene Hydrochloride; Recurrence; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2006 |
Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial.
Topics: Adult; Chronic Disease; Endometriosis; Female; Humans; Laparoscopy; Pelvic Pain; Quality of Life; Raloxifene Hydrochloride; Recurrence; Selective Estrogen Receptor Modulators; Treatment Outcome | 2008 |
6 other study(ies) available for raloxifene hydrochloride and Endometriosis
| Article | Year |
|---|---|
Role of nociceptor estrogen receptor GPR30 in a rat model of endometriosis pain.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Estrogen Antagonists; Female; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Nociceptors; Oligonucleotides, Antisense; Pain Threshold; Pelvic Pain; Protein Kinase C-epsilon; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger | 2014 |
Comparison of the effects of raloxifene and anastrozole on experimental endometriosis.
Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Endometriosis; Female; Nitriles; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Single-Blind Method; Triazoles | 2010 |
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis.
Topics: Animals; Cadherins; Cell Proliferation; Endometriosis; Endometrium; Epithelial Cells; Estradiol; Estrogens; Female; Humans; Menstruation; Mesenchymal Stem Cells; Mice; Mice, SCID; Raloxifene Hydrochloride; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Snail Family Transcription Factors; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Up-Regulation | 2010 |
Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women.
Topics: Adolescent; Adult; Cohort Studies; Endometriosis; Estrogen Antagonists; Female; Humans; Laparoscopy; Middle Aged; Ovary; Raloxifene Hydrochloride; Urinary Bladder; Uterus | 2008 |
Adenomyosis--a result of disordered stromal differentiation.
Topics: Administration, Oral; Aging; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; Cell Differentiation; Endometriosis; Estradiol; Female; Gene Expression Regulation; Growth Inhibitors; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Myometrium; Nerve Growth Factor; Oligonucleotide Array Sequence Analysis; Organ Size; Raloxifene Hydrochloride; Repressor Proteins; Selective Estrogen Receptor Modulators; Stromal Cells; Tamoxifen; Toremifene; Uterus | 2001 |
Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
Topics: Adult; Case-Control Studies; Cell Line; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Hormones; Humans; Middle Aged; Ovary; Plasminogen Activator Inhibitor 1; Progesterone; Raloxifene Hydrochloride; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Stromal Cells; Urokinase-Type Plasminogen Activator | 2002 |